Income Statement (TTM)
Basilea Pharmaceutica AG Income Statement shows changes in income and expenses over a period of time. Income Statement data includes Sales and Revenue, Gross Profit, Research and Development (R&D), Selling, General and Administrative Expense (SG&A), Operating Income, Income Tax Expense, Interest Expense, Non-Operating Income, Earnings per Share (EPS), and Shares Outstanding.
All numbers are times 1,000,000 except per share units.
|
2020 09-30 |
2020 12-31 |
2021 03-31 |
2021 06-30 |
2021 09-30 |
2021 12-31 |
2022 03-31 |
2022 06-30 |
2022 09-30 |
2022 12-31 |
2023 03-31 |
2023 06-30 |
2023 09-30 |
2023 12-31 |
2024 03-31 |
2024 06-30 |
2024 09-30 |
2024 12-31 |
2025 03-31 |
2025 06-30 |
|
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 134 | 128 | 120 | 112 | 130 | 148 | 150 | 152 | 150 | 148 | 161 | 175 | 166 | 158 | 153 | 149 | 179 | 209 | 222 | 236 |
| Change (%) | -4.81 | -5.93 | -6.30 | 15.83 | 13.67 | 1.16 | 1.15 | -1.26 | -1.27 | 9.22 | 8.44 | -4.97 | -5.23 | -2.73 | -2.81 | 19.97 | 16.65 | 6.63 | 6.22 | |
| % of Revenue | 100.00 | 100.00 | 100.00 | 100.00 | 100.00 | 100.00 | 100.00 | 100.00 | 100.00 | 100.00 | 100.00 | 100.00 | 100.00 | 100.00 | 100.00 | 100.00 | 100.00 | 100.00 | 100.00 | 100.00 |
| Cost Of Sales | 120 | 121 | 121 | 120 | 118 | 117 | 116 | 114 | 106 | 98 | 88 | 78 | 91 | 105 | 115 | 125 | 120 | 116 | 121 | 127 |
| Change (%) | 1.30 | -0.75 | -0.75 | -1.01 | -1.02 | -1.34 | -1.36 | -6.87 | -7.38 | -10.47 | -11.69 | 17.25 | 14.71 | 9.68 | 8.82 | -3.63 | -3.77 | 4.67 | 4.46 | |
| % of Revenue | 89.43 | 95.17 | 100.41 | 106.36 | 90.89 | 79.14 | 77.18 | 75.27 | 70.99 | 66.60 | 54.59 | 44.45 | 54.85 | 66.39 | 74.85 | 83.81 | 67.32 | 55.54 | 54.51 | 53.61 |
| Gross Operating Profit | 14 | 6 | -0 | -7 | 12 | 31 | 34 | 37 | 43 | 49 | 73 | 97 | 75 | 53 | 39 | 24 | 58 | 93 | 101 | 110 |
| Change (%) | -56.50 | -108.03 | 1,345.45 | -265.88 | 160.28 | 10.68 | 9.65 | 15.83 | 13.67 | 48.48 | 32.65 | -22.75 | -29.45 | -27.24 | -37.43 | 142.18 | 58.71 | 9.09 | 8.33 | |
| % of Revenue | 10.57 | 4.83 | -0.41 | -6.36 | 9.11 | 20.86 | 22.82 | 24.73 | 29.01 | 33.40 | 45.41 | 55.55 | 45.15 | 33.61 | 25.15 | 16.19 | 32.68 | 44.46 | 45.49 | 46.39 |
| SG&A | 27 | 28 | 28 | 27 | 28 | 28 | 28 | 29 | 29 | 29 | 29 | 29 | 30 | 31 | 31 | 31 | 31 | 31 | 32 | 33 |
| Change (%) | 0.79 | -0.20 | -0.20 | 0.76 | 0.75 | 1.65 | 1.62 | -0.45 | -0.45 | 1.38 | 1.36 | 2.98 | 2.90 | -0.16 | -0.16 | 0.06 | 0.06 | 3.21 | 3.11 | |
| % of Revenue | 20.41 | 21.61 | 22.92 | 24.42 | 21.24 | 18.83 | 18.92 | 19.00 | 19.16 | 19.32 | 17.93 | 16.76 | 18.16 | 19.72 | 20.24 | 20.79 | 17.34 | 14.88 | 14.40 | 13.98 |
| R&D | ||||||||||||||||||||
| Change (%) | ||||||||||||||||||||
| % of Revenue | ||||||||||||||||||||
| OpEx | 147 | 149 | 148 | 147 | 146 | 145 | 144 | 143 | 135 | 127 | 117 | 107 | 121 | 136 | 146 | 156 | 151 | 147 | 153 | 160 |
| Change (%) | 1.21 | -0.64 | -0.65 | -0.68 | -0.69 | -0.77 | -0.77 | -5.58 | -5.90 | -7.81 | -8.47 | 13.34 | 11.77 | 7.42 | 6.91 | -2.90 | -2.98 | 4.36 | 4.18 | |
| % of Revenue | 109.84 | 116.78 | 123.34 | 130.78 | 112.13 | 97.97 | 96.10 | 94.27 | 90.15 | 85.91 | 72.52 | 61.21 | 73.01 | 86.10 | 95.09 | 104.60 | 84.66 | 70.41 | 68.91 | 67.59 |
| Operating Income | -13 | -21 | -28 | -35 | -16 | 3 | 6 | 9 | 15 | 21 | 44 | 68 | 45 | 22 | 8 | -7 | 27 | 62 | 69 | 77 |
| Change (%) | 62.36 | 30.85 | 23.58 | -54.34 | -119.03 | 94.38 | 48.55 | 69.81 | 41.11 | 113.09 | 53.07 | -33.86 | -51.21 | -65.65 | -191.16 | -499.76 | 125.02 | 12.05 | 10.75 | |
| % of Revenue | -9.84 | -16.78 | -23.34 | -30.78 | -12.13 | 2.03 | 3.90 | 5.73 | 9.85 | 14.09 | 27.48 | 38.79 | 26.99 | 13.90 | 4.91 | -4.60 | 15.34 | 29.59 | 31.09 | 32.41 |
| Interest Expense | -7 | -8 | -8 | -9 | -8 | -8 | -8 | -8 | -9 | -10 | -11 | -12 | -12 | -11 | -10 | -8 | -6 | -4 | -4 | -4 |
| Change (%) | 8.92 | 6.46 | 6.07 | -2.44 | -2.50 | -1.90 | -1.94 | 12.80 | 11.35 | 10.04 | 9.13 | -2.64 | -2.71 | -14.62 | -17.13 | -22.60 | -29.19 | -6.87 | -7.38 | |
| % of Revenue | -5.20 | -5.95 | -6.73 | -7.62 | -6.42 | -5.50 | -5.34 | -5.17 | -5.91 | -6.66 | -6.71 | -6.76 | -6.92 | -7.11 | -6.24 | -5.32 | -3.43 | -2.08 | -1.82 | -1.59 |
| Net Income | -6 | -15 | -30 | -45 | -26 | -7 | -3 | 1 | 6 | 12 | 34 | 56 | 33 | 10 | 5 | -1 | 38 | 78 | 75 | 73 |
| Change (%) | 150.12 | 101.32 | 50.33 | -42.33 | -73.41 | -56.23 | -128.46 | 663.69 | 86.91 | 181.32 | 64.45 | -40.70 | -68.64 | -53.12 | -113.31 | -6,000.38 | 101.69 | -3.18 | -3.28 | |
| % of Revenue | -4.39 | -11.53 | -24.69 | -39.60 | -19.72 | -4.61 | -2.00 | 0.56 | 4.34 | 8.22 | 21.17 | 32.11 | 20.03 | 6.63 | 3.20 | -0.44 | 21.52 | 37.21 | 33.78 | 30.76 |
Source: Capital IQ
